Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia
Authors
Keywords
IL-33, sST2, HMGB1, S100B, Schizophrenia, Biomarkers
Journal
JOURNAL OF PSYCHIATRIC RESEARCH
Volume 138, Issue -, Pages 380-387
Publisher
Elsevier BV
Online
2021-04-29
DOI
10.1016/j.jpsychires.2021.04.019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alarmins HMGB1, IL-33, S100A7, and S100A12 in Psoriasis Vulgaris
- (2020) Pavel Borsky et al. MEDIATORS OF INFLAMMATION
- IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment
- (2020) Marina Saresella et al. Journal of Neuroinflammation
- The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation
- (2020) Ashley L. Comer et al. Frontiers in Cellular Neuroscience
- Peripheral Biomarkers for First-Episode Psychosis—Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia
- (2019) Nuno Trovão et al. Psychiatry Investigation
- Dual faced HMGB1 plays multiple roles in cardiomyocyte senescence and cardiac inflammatory injury
- (2019) Hongxiang Lu et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The Role of High Mobility Group Box 1 in Ischemic Stroke
- (2019) Yingze Ye et al. Frontiers in Cellular Neuroscience
- Serum Levels of High Sensitivity C-reactive Protein in Drug-naïve First-episode Psychosis and Acute Exacerbation of Schizophrenia
- (2019) Abdullah Bolu et al. Clinical Psychopharmacology and Neuroscience
- Increased plasma levels of high mobility group box 1 protein in patients with bipolar disorder: A pilot study
- (2019) Cynthia Marie-Claire et al. JOURNAL OF NEUROIMMUNOLOGY
- Serum high-sensitivity C-reactive protein levels are positively associated with cognitive impairments in patients with first-episode schizophrenia
- (2019) Jing Zhu et al. COMPREHENSIVE PSYCHIATRY
- Schizophrenia—An Overview
- (2019) Robert A. McCutcheon et al. JAMA Psychiatry
- DAMPs and NETs in Sepsis
- (2019) Naomi-Liza Denning et al. Frontiers in Immunology
- Cytokine Alterations in Schizophrenia: An Updated Review
- (2019) Sara Momtazmanesh et al. Frontiers in Psychiatry
- Depression and sterile inflammation: Essential role of danger associated molecular patterns
- (2018) Tina C. Franklin et al. BRAIN BEHAVIOR AND IMMUNITY
- High-mobility group box 1 in Parkinson's disease: from pathogenesis to therapeutic approaches
- (2018) Efthalia Angelopoulou et al. JOURNAL OF NEUROCHEMISTRY
- IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis
- (2018) Milica M. Borovcanin et al. Frontiers in Psychiatry
- The S100B story: From biomarker to active factor in neural injury
- (2018) Fabrizio Michetti et al. JOURNAL OF NEUROCHEMISTRY
- Damage-Associated Molecular Patterns in Inflammatory Diseases
- (2018) Jong Seong Roh et al. Immune Network
- High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson’s disease
- (2018) Aslıhan Baran et al. NEUROLOGICAL SCIENCES
- Pattern Recognition Receptors and the Host Cell Death Molecular Machinery
- (2018) Gustavo P. Amarante-Mendes et al. Frontiers in Immunology
- Alarmins and immunity
- (2017) De Yang et al. IMMUNOLOGICAL REVIEWS
- Alarmins: Feel the Stress
- (2017) Peleg Rider et al. JOURNAL OF IMMUNOLOGY
- 30 Years on: How the Neurodevelopmental Hypothesis of Schizophrenia Morphed Into the Developmental Risk Factor Model of Psychosis
- (2017) Robin M Murray et al. SCHIZOPHRENIA BULLETIN
- The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
- (2017) Brad Griesenauer et al. Frontiers in Immunology
- A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury
- (2016) Eric Peter Thelin et al. ACTA NEUROCHIRURGICA
- HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins
- (2016) Damien Bertheloot et al. Cellular & Molecular Immunology
- Cystic Fibrosis Lung Immunity: The Role of the Macrophage
- (2016) Emanuela M. Bruscia et al. Journal of Innate Immunity
- In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin
- (2016) Matteo Santoro et al. NEUROBIOLOGY OF DISEASE
- Damage-associated molecular patterns in cancer: a double-edged sword
- (2016) C Hernandez et al. ONCOGENE
- IL-33 ameliorates Alzheimer’s disease-like pathology and cognitive decline
- (2016) Amy K. Y. Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Higher Plasma S100B Concentrations in Schizophrenia Patients and Dependently Associated with Inflammatory Markers
- (2016) Wu Hong et al. Scientific Reports
- IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases
- (2015) Lavinia Vocca et al. IMMUNOBIOLOGY
- A preliminary report of increased plasma levels of IL-33 in bipolar disorder: Further evidence of pro-inflammatory status
- (2014) Izabela Guimaraes Barbosa et al. JOURNAL OF AFFECTIVE DISORDERS
- Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder
- (2014) Adam Wysokiński et al. NORDIC JOURNAL OF PSYCHIATRY
- Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis
- (2013) Valérie Tourjman et al. SCHIZOPHRENIA RESEARCH
- Functions of S100 Proteins
- (2012) R. Donato et al. CURRENT MOLECULAR MEDICINE
- Alarmins: awaiting a clinical response
- (2012) James K. Chan et al. JOURNAL OF CLINICAL INVESTIGATION
- HMGB1 in Development and Diseases of the Central Nervous System
- (2012) Ping Fang et al. MOLECULAR NEUROBIOLOGY
- Role of IL-33 in inflammation and disease
- (2011) Ashley M Miller Journal of Inflammation-London
- The S100B protein in biological fluids: more than a lifelong biomarker of brain distress
- (2011) Fabrizio Michetti et al. JOURNAL OF NEUROCHEMISTRY
- Serum levels of S100B and NSE proteins in Alzheimer's disease patients
- (2010) Márcia L Chaves et al. Journal of Neuroinflammation
- Increased serum S100B in never-medicated and medicated schizophrenic patients
- (2010) Xiang Yang Zhang et al. JOURNAL OF PSYCHIATRIC RESEARCH
- White Blood Cell Count and C-Reactive Protein Are Independent Predictors of Mortality in the Oldest Old
- (2010) J. M. Willems et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics
- (2009) Ling Yan Qi et al. NEUROSCIENCE LETTERS
- Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia — Original research and meta-analysis
- (2009) Matthias L. Schroeter et al. PSYCHIATRY RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search